In case you missed the primary webinar, you’ll be able to WATCH IT HERE.
For the previous decade, Harris Bricken attorneys have suggested home and worldwide companies and entrepreneurs on quickly evolving legal guidelines and laws within the hashish, hemp, and controlled substances industries.
Over the previous few years, our attorneys have led the way in which on advising buyers, companies, and entrepreneurs in rising drug therapies – psilocybin, ketamine infusion clinics, MDMA and different psychedelic substances. We discussed these topics stay again on July 9, and now, by well-liked demand, we will likely be internet hosting a observe up webinar.
On Thursday, November 19, 2020 at 12pm PT, Harris Bricken attorneys will tackle the outcomes of the elections and different latest developments associated to psychedelic medication and new drug therapies. We’ll have a look at the method and outcomes for Measure 109 (psilocybin licensing) and Measure 110 (managed substance decriminalization) in Oregon, in addition to future efforts to decriminalize, shield and regulate psychedelic drug use. The dialog will cowl all the pieces from religious exemptions to commercial opportunities.
The panel will likely be moderated by Vince Sliwoski (Portland), with panelists Griffen Thorne (Los Angeles), Alison Malsbury (San Francisco), and Jesse Mondry (Portland). The panelists will take questions all through the presentation.